Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


14.05.2018

1 Ann Surg Oncol
2 Anticancer Res
1 BMC Cancer
1 Cancer Res
1 Clin Cancer Res
1 Dig Dis
19 Dis Colon Rectum
2 Eur J Cancer
1 Eur J Surg Oncol
2 Gastroenterology
1 Int J Colorectal Dis
4 Int J Oncol
1 Lancet Oncol
1 N Engl J Med
3 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
    Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
    PubMed     Text format    


    Anticancer Res

  2. ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
    Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
    Anticancer Res. 2018;38:3069-3077.
    PubMed     Text format     Abstract available

  3. SIDERIS M, Donaldson AN, Hanrahan J, Grunwald M, et al
    Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.
    Anticancer Res. 2018;38:1879-1895.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. SHULDINER J, Liu Y, Lofters A
    Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014.
    BMC Cancer. 2018;18:537.
    PubMed     Text format     Abstract available


    Cancer Res

  5. ULLMANN P, Rodriguez F, Schmitz M, Meurer SK, et al
    The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-3003.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  6. TOWNSEND A, Tebbutt NC, Karapetis CS, Cooper P, et al
    PHASE IB/II STUDY OF SECOND LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN KRAS WILD TYPE METASTATIC COLORECTAL CANCER.
    Clin Cancer Res. 2018 May 8. pii: 1078-0432.CCR-17-3590.
    PubMed     Text format     Abstract available


    Dig Dis

  7. SUGIMOTO S, Hotta K, Shimoda T, Imai K, et al
    Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
    Dig Dis. 2018;36:118-122.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  8. MATHUS-VLIEGEN EMH, van der Vliet K, Wignand-van der Storm IJ, Stadwijk JS, et al
    Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The
    Dis Colon Rectum. 2018;61:239-249.
    PubMed     Text format     Abstract available

  9. TANAKA A, Sadahiro S, Suzuki T, Okada K, et al
    Comparisons of Rigid Proctoscopy, Flexible Colonoscopy, and Digital Rectal Examination for Determining the Localization of Rectal Cancers.
    Dis Colon Rectum. 2018;61:202-206.
    PubMed     Text format     Abstract available

  10. CORINES MJ, Nougaret S, Weiser MR, Khan M, et al
    Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer.
    Dis Colon Rectum. 2018;61:193-201.
    PubMed     Text format     Abstract available

  11. TSANG ES, McConnell YJ, Schaeffer DF, Yin Y, et al
    Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
    Dis Colon Rectum. 2018;61:187-192.
    PubMed     Text format     Abstract available

  12. GUERRA GR, Kong JC, Bernardi MP, Ramsay RG, et al
    Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma.
    Dis Colon Rectum. 2018;61:179-186.
    PubMed     Text format     Abstract available

  13. LEE L, Althoff A, Edwards K, Albert MR, et al
    Outcomes of Closed Versus Open Defects After Local Excision of Rectal Neoplasms: A Multi-institutional Matched Analysis.
    Dis Colon Rectum. 2018;61:172-178.
    PubMed     Text format     Abstract available

  14. OUCHI A, Komori K, Kimura K, Kinoshita T, et al
    Survival Benefit of Japanese Extended Lymphadenectomy for Clinically Node-Negative and Node-Positive Colorectal Cancers.
    Dis Colon Rectum. 2018;61:162-171.
    PubMed     Text format     Abstract available

  15. BROWN S, Margolin DA, Altom LK, Green H, et al
    Morbidity Following Coloanal Anastomosis: A Comparison of Colonic J-Pouch vs Straight Anastomosis.
    Dis Colon Rectum. 2018;61:156-161.
    PubMed     Text format     Abstract available

  16. SHAPIRO J, de Graaf JJJC, Doornebosch PG, Vermaas M, et al
    Laparoscopic Rectovaginopexy for Neorectal Prolapse After Transanal Total Mesorectal Excision.
    Dis Colon Rectum. 2018;61:260.
    PubMed     Text format    

  17. LEE DJK, Wang KY, Sagar PM, Timothy J, et al
    S1 Sacrectomy for Re-recurrent Rectal Cancer: Our Experience with Reconstruction Using an Expandable Vertebral Body Replacement Device.
    Dis Colon Rectum. 2018;61:261-265.
    PubMed     Text format     Abstract available

  18. CRANSTON RD, Baker JR, Siegel A, Brand RM, et al
    A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1-Infected Men With High-Grade Squamous Intraepithelial Lesions.
    Dis Colon Rectum. 2018;61:298-305.
    PubMed     Text format     Abstract available

  19. KANDA M, Oba K, Aoyama T, Kashiwabara K, et al
    Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.
    Dis Colon Rectum. 2018;61:461-471.
    PubMed     Text format     Abstract available

  20. WARRIER SK, Kong JC, Guerra GR, Chittleborough TJ, et al
    Risk Factors Associated With Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study.
    Dis Colon Rectum. 2018;61:433-440.
    PubMed     Text format     Abstract available

  21. PAUL BK, Ihemelandu C, Sugarbaker PH
    Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Che
    Dis Colon Rectum. 2018;61:347-354.
    PubMed     Text format     Abstract available

  22. BAXTER NN, Fischer HD, Richardson DP, Urbach DR, et al
    A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab.
    Dis Colon Rectum. 2018;61:306-313.
    PubMed     Text format     Abstract available

  23. TOH JWT, Matthews R, Kim SH
    Arc of Riolan-Preserving Splenic Flexure Takedown During Anterior Resection: Potentially Critical to Prevent Acute Anastomotic Ischemia.
    Dis Colon Rectum. 2018;61:411-414.
    PubMed     Text format     Abstract available

  24. LAMBREGTS DMJ, Delli Pizzi A, Lahaye MJ, van Griethuysen JJM, et al
    A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Dis Colon Rectum. 2018 Jan 23. doi: 10.1097/DCR.0000000000000915.
    PubMed     Text format     Abstract available

  25. KWAK MS, Chung SJ, Yang JI, Im JP, et al
    Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy.
    Dis Colon Rectum. 2018;61:338-346.
    PubMed     Text format     Abstract available

  26. OKUNO T, Kawai K, Koyama K, Takahashi M, et al
    Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.
    Dis Colon Rectum. 2018 Jan 22. doi: 10.1097/DCR.0000000000000959.
    PubMed     Text format     Abstract available


    Eur J Cancer

  27. AUCLIN E, Andre T, Taieb J, Benetkiewicz M, et al
    Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments.
    Eur J Cancer. 2018 May 3. pii: S0959-8049(18)30782.
    PubMed     Text format    

  28. GOEY KKH, Mahmoud R, Sorbye H, Glimelius B, et al
    Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review.
    Eur J Cancer. 2018;96:115-124.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  29. BROUWER NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, et al
    Clinical lymph node staging in colorectal cancer; a flip of the coin?
    Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31013.
    PubMed     Text format     Abstract available


    Gastroenterology

  30. PEERY AF, Cools KS, Strassle PD, McGill SK, et al
    Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States.
    Gastroenterology. 2018;154:1352-1360.
    PubMed     Text format     Abstract available

  31. KWONG TNY, Wang X, Nakatsu G, Chow TC, et al
    Association Between Bacteremia from Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
    Gastroenterology. 2018 May 2. pii: S0016-5085(18)30489.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  32. ABUKAR AA, Ramsanahie A, Martin-Lumbard K, Herrington ER, et al
    Availability and feasibility of structured, routine collection of comorbidity data in a colorectal cancer multi-disciplinary team (MDT) setting.
    Int J Colorectal Dis. 2018 May 3. pii: 10.1007/s00384-018-3062.
    PubMed     Text format     Abstract available


    Int J Oncol

  33. LEE DH, Won HR, Ryu HW, Han JM, et al
    The HDAC6 inhibitor ACY1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4405.
    PubMed     Text format     Abstract available

  34. SU MQ, Zhou YR, Rao X, Yang H, et al
    Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4402.
    PubMed     Text format     Abstract available

  35. LI X, Zhao X, Yang B, Li Y, et al
    Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.
    Int J Oncol. 2018 May 9. doi: 10.3892/ijo.2018.4400.
    PubMed     Text format     Abstract available

  36. PARK BK, Park JY, Kim TH, Kim D, et al
    Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
    Int J Oncol. 2018 Apr 26. doi: 10.3892/ijo.2018.4385.
    PubMed     Text format     Abstract available


    Lancet Oncol

  37. BURKI T
    Flexible sigmoidoscopy screening for colorectal cancer.
    Lancet Oncol. 2018 May 3. pii: S1470-2045(18)30346.
    PubMed     Text format    


    N Engl J Med

  38. CHEN PY
    Colon Cutoff Sign.
    N Engl J Med. 2018;378:1621.
    PubMed     Text format    


    Oncol Rep

  39. LI C, Du X, Xia S, Chen L, et al
    MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6406.
    PubMed     Text format     Abstract available

  40. FUJINO S, Kinugasa T, Sudo T, Mizobe T, et al
    Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6407.
    PubMed     Text format     Abstract available

  41. YANG H, Wang S, Kang YJ, Wang C, et al
    Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6412.
    PubMed     Text format     Abstract available


    PLoS One

  42. KOJIMA K, Nakamura T, Ohbu M, Katoh H, et al
    Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    PLoS One. 2018;13:e0194785.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: